U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H20HgNO6.HO
Molecular Weight 527.92
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MERETHOXYLLINE

SMILES

[OH-].COCCOC(C[Hg+])CNC(=O)C1=C(OCC(O)=O)C=CC=C1

InChI

InChIKey=NQNRRALXOYEOGG-UHFFFAOYSA-M
InChI=1S/C15H20NO6.Hg.H2O/c1-11(21-8-7-20-2)9-16-15(19)12-5-3-4-6-13(12)22-10-14(17)18;;/h3-6,11H,1,7-10H2,2H3,(H,16,19)(H,17,18);;1H2/q;+1;/p-1

HIDE SMILES / InChI

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C15H20HgNO6
Molecular Weight 510.91
Charge 1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Merethoxylline is a mercurial diuretic. As an equimolar mixture of merethoxylline procaine and theophylline in the molecular proportion 1:1.4 (DICURIN PROCAINE, Lilly) has been used in the treatment of oedema and ascites. The procaine component helps in reducing the discomfort of local irritation caused by mercurial compound when injected into tissues.

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DICURIN PROCAINE
Primary
DICURIN PROCAINE

Sourcing

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Ususal i.m., s.c. daily 0.5 to 5 ml (containing 100 mg procaine merethoxylline and 50 mg of theophylline per ml)
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
1AQ60H5GT2
Record Status Validated (UNII)
Record Version